Durable Clinical Responses and Long-Term Follow-Up of Stage III –IV Non-Small-Cell Lung Cancer (NSCLC) Patients Treated With IDO Peptide Vaccine in a Phase I Study—A Brief Research Report

Julie Westerlin Kjeldsen, Trine Zeeberg Iversen, Lotte Engell-Noerregaard, Anders Mellemgaard, Mads Hald Andersen, Inge Marie Svane
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research